Skip to Main Content

Paper Details

Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses.
Blood Adv
12
2021
Author NameAffiliation
Tara L LinUniversity of Kansas Medical Center
David A RizzieriDuke Comprehensive Cancer Center
John T SchillerDavid Geffen School of Medicine at university of california los angeles
Jorge CortesUniversity of Texas MD Anderson Cancer Center
Jorge CortesGeorgia Cancer Center, Augusta University
  • 1 - 5

Datasets

Release 1.2